Overview

Yair Ziv is partner in the Intellectual Property Practice Group of the firm. He has extensive experience representing clients before all levels of Israeli courts, as well as the Israel Patent Office, on patent infringement actions, oppositions, revocations, patent term extensions and the enforcement and protection of patents, whether as a domestic action or as part of a coordinated international enforcement action or proceedings challenging an IP right.

Yair represents major global and domestic pharmaceutical companies, generic manufacturers and technology companies. He also has particular expertise advising on the regulatory aspects of testing, marketing and selling pharmaceuticals and medical devices in Israel.

As a science graduate, Yair possesses the necessary background to understand both the technical, as well as the legal, issues facing the pharmaceutical and life sciences sectors. Together with other members of the Practice Group, he is involved in the legislative processes to amend Israel’s Patents Law and other regulations applicable to the pharmaceutical and life science sector.

Yair joined S. Horowitz & Co. in 2007, where he completed his internship and qualified as an Israeli advocate.

Publications:

  • Co-author of the Israel chapter in: “Patent Protection for Second Medical Uses” (Wolters Kluwer, 2020).
  • Co-author of the Israel chapter in: “Study on the Legal Aspects of Supplementary Protection Certificates in the EU” (the European Commission, 2018).
  • Co-author of the Israel chapter in: “Patent Protection for Second Medical Uses” (Wolters Kluwer, September, 2016).
Languages: EnglishHebrew
Admissions: Israel Bar, 2008
Education: Hebrew University of Jerusalem, LL.B., cum laude and Dean’s List (2007)Hebrew University of Jerusalem, B.Sc. (Biology), Dean’s List (2004)

Experience

  • Advising Teva Pharmaceutical Industries Ltd. in numerous patent opposition proceedings and providing ongoing advice on various aspects of patents law, including freedom to operate opinions.
  • Representing Simplivia Healthcare Ltd. in patent infringement actions with respect to a drug mixing system.
  • Representing the Chemical, Pharmaceutical and Environmental Society of the Manufacturers’ Association of Israel in the drafting of IP legislation in Israel, including providing advice on proposed amendments to Israeli law on several patent issues.
  • Representing the Chemical, Pharmaceutical and Environmental Society of the Manufacturers’ Association of Israel in various cases involving issues of principle concerning patents and patent-term extensions, before all levels of Israeli courts and the Israel Patent Office.
  • Representing Smart Shooter Ltd. in several proceedings, including patent oppositions and trade secrets litigation.
  • Representing Dexcel Pharma Ltd. in high-value class actions brought against the company and other companies alleging the failure, on the part of Dexcel, to comply with regulatory requirements with respect to the contents of marketing materials.

Recognition

  • The Legal 500 2020: Yair Ziv was featured in the “Next Generation Partners” category in the intellectual property disputes field: “a standout younger partner.”

Other Activities

  • Member of AIPPI – the International Association for the Protection of Intellectual Property.
  • Member of the Intellectual Property Committee of the Israel Bar Association.

Terms of Use

Please read these Terms of Use (the “Terms”) carefully before using the Website. If you do not agree to any of the provisions in these Terms, please do not use the Website.

The content and materials appearing on the Website are provided for general informational purposes only and do not constitute, nor should be relied upon as, legal or other professional advice.

 

General

 

Disclaimers and Limitation of Liability

 

Intellectual Property

 

Data Security

 

Code of Conduct

 

Governing Law
Contact Information

 

I Agree